← SynDRA
Thiamet G, >=98% (HPLC)
SynDRA canonical compound SYN0657459 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MGEA5 |
|---|
| Mechanism of action | GLCNAC phosphotransferase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- HMS3648I18
- EX-A2240
- s7213
- AKOS024458135
- CCG-266939
- NCGC00344096-09
- AC-32945
- BS-14158
- HY-12588
- T6056
- SR-01000946377
- SR-01000946377-1
- Thiamet G
- RefChem:932942
- MFCD15144964
- 2vvn
- orb1301113
- SCHEMBL1898821
- GTPL10509
- PPAIMZHKIXDJRN-FMDGEEDCSA-N
- GLXC-06821
- BDBM50323697
- MD08856
- NCGC00344096-03
- SY272299
- SW219118-1
- D83468
- BRD-K38380126-001-01-4
- (3ar,5R,6S,7R,7ar)-2-(ethylamino)-5-(hydroxymethyl)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-D][1,3]thiazole-6,7-diol
Look up Thiamet G, >=98% (HPLC) in the interactive SynDRA portal →